Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/THOR-MEDICAL-21296150/actualite/Nordic-Nanovector-ASA-abandonne-Paradigme-son-essai-de-phase-2B-avec-Betalutin-dans-le-lymphome-40907185/?utm_source=whatsapp&utm_medium=social&utm_campaign=share